EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low Plasma Carnosinase-1 Activity in Patients with Left Ventricular Systolic Dysfunction: Implications for Carnosine Therapy in Heart Failure

I-Chau Liang iD, Ettore Gilardoni, Islam A Berdaweel iD, Knute D Carter, Ethan J Anderson iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von I-Chau Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Carnosine, Dipeptidases, Heart Failure, Ventricular Dysfunction, Left. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic efficacy of histidyl dipeptides such as carnosine is hampered by circulating carnosinase-1 (CN1), which catalyzes carnosine’s hydrolysis and degradation. Prior reports suggest that oral carnosine may improve cardiometabolic parameters in patients with heart failure (HF), but whether CN1 activity is affected by HF is unknown. Here, we measured CN1 content and carnosine degradation rate (CDR) in preoperative plasma samples from a cohort of patients (n = 138) undergoing elective cardiac surgery to determine whether plasma CN1 and/or CDR varied with left ventricular (LV) systolic dysfunction. CN1 content was normally distributed in the cohort, but plasma CDR displayed a quasi-bimodal distribution into high- (>2 nmol/(h*μL)) and low-activity (≤2 nmol/(h*μL)) clusters. Multivariable analysis confirmed female sex, diabetes and LV systolic dysfunction was associated with the low-activity CDR cluster. Although CN1 content did not differ, logistic regression analysis revealed that CDR and CN1-specific activity (CDR/CN1 content) was significantly lower in patients with both moderate (ejection fraction, EF ≥ 35 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnosineDipeptidasesHeart FailureVentricular Dysfunction, LeftHumansFemaleMaleAgedMiddle Aged

Stichwörter der Autor:innen

CN1 proteinCNDP1carnosinasecarnosineheart failure

Substanzen

CarnosineDipeptidasesaminoacyl-histidine dipeptidase

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Clinical Pharmacy and Pharmacy Practice, Yarmouk University, Irbid 21163, Jordan.
  • Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 52242, USA.
  • Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA 52242, USA.
  • Abboud Cardiovascular Research Center, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: I-Chau Liang, Islam A Berdaweel, Ethan J Anderson

Förderung

  • NHLBI NIH HHS
  • American Heart Association
  • National Institutes of Health

Zitieren

APA

Liang, I. C., Gilardoni, E., Berdaweel, I. A., Carter, K. D., & Anderson, E. J. (2025). Low Plasma Carnosinase-1 Activity in Patients with Left Ventricular Systolic Dysfunction: Implications for Carnosine Therapy in Heart Failure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062608

Vancouver

Liang IC, Gilardoni E, Berdaweel IA, Carter KD, Anderson EJ. Low Plasma Carnosinase-1 Activity in Patients with Left Ventricular Systolic Dysfunction: Implications for Carnosine Therapy in Heart Failure. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062608

BibTeX
@article{Liang2025,
  author = {Liang, I-Chau and Gilardoni, Ettore and Berdaweel, Islam A and Carter, Knute D and Anderson, Ethan J},
  title = {Low Plasma Carnosinase-1 Activity in Patients with Left Ventricular Systolic Dysfunction: Implications for Carnosine Therapy in Heart Failure},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062608}
}
Kostenlos starten →